Cartesian Therapeutics
RNAC
#7689
Rank
S$0.34 B
Marketcap
$13.46
Share price
-18.96%
Change (1 day)
-25.09%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -S$0.11 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are S$38.91 Million. , an increase over its 2023 earnings that were of -S$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -S$0.11 Billion-67.3%
2023 -S$0.32 Billion-724%
2022 S$50.86 M-649.67%
2021 -S$9.26 Million-89.78%
2020 -S$90.58 Million25.06%
2019 -S$72.43 Million-15.68%
2018 -S$85.9 Million-0.43%
2017 -S$86.27 Million83.41%
2016 -S$47.04 Million44.3%
2015 -S$32.6 Million